Management of primary cutaneous lymphoma patients during COVID‐19 pandemic: EORTC CLTF guidelines

Linked articles: COVID‐19 SPECIAL FORUM. J Eur Acad Dermatol Venereol 2020; 34: e346–e380.

Saved in:
Bibliographic Details
Published inJournal of the European Academy of Dermatology and Venereology Vol. 34; no. 8; pp. 1633 - 1636
Main Authors Papadavid, E., Scaribrick, J., Ortiz Romero, P., Guaglino, P., Vermeer, M., Knobler, R., Stadler, R., Bagot, M.
Format Journal Article
LanguageEnglish
Published England John Wiley and Sons Inc 01.08.2020
Subjects
Betacoronavirus - isolation & purification
Commentaries
Coronavirus Infections - complications
Coronavirus Infections - epidemiology
Coronavirus Infections - virology
COVID-19
Humans
Lymphoma, T-Cell, Cutaneous - complications
Lymphoma, T-Cell, Cutaneous - therapy
Pandemics
Pneumonia, Viral - complications
Pneumonia, Viral - epidemiology
Pneumonia, Viral - virology
Practice Guidelines as Topic
SARS-CoV-2
Skin Neoplasms - complications
Skin Neoplasms - therapy
Online AccessGet full text

Cover

More Information
Summary:Linked articles: COVID‐19 SPECIAL FORUM. J Eur Acad Dermatol Venereol 2020; 34: e346–e380.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
Correction added on 30 October, after first online publication: One of the authors’ names was changed after publication.
ISSN:0926-9959
1468-3083
DOI:10.1111/jdv.16593